Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Cancer Research and Treatment|February 18, 2015
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung CancerJae Myoung Noh, Yong Chan Ahn, Hyebin Lee, et al.Cancer Research and Treatment|February 20, 2024
Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective StudiesSung Wook Cho, Sung Hee Lim, Ghee Young Kwon, et al.Cancer Research and Treatment|February 18, 2015
Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent ChemoradiotherapyJae Myoung Noh, Jin Man Kim, Yong Chan Ahn, et al.Journal of Thoracic Disease|July 10, 2020
Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgerySumin Shin, Hong Kwan Kim, Jong Ho Cho, et al.Cancer Research and Treatment|September 12, 2018
Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung CancerKyung Hwa Lee, Yong Chan Ahn, Hongryull Pyo, et al.Radiation Oncology Journal|January 8, 2024
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancerSang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, et al.Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancerJunghee Lee, Hong Kwan Kim, Byung Jo Park, et al.Scientific Reports|April 8, 2024
Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Radiation Oncology Journal|July 1, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for clinically node-positive prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Journal of Medical Imaging and Radiation Oncology|March 13, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Pageof 9